• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于疫苗应用的狂犬病病毒样颗粒的研发:生产、特性鉴定及保护研究。

Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies.

作者信息

Fontana Diego, Etcheverrigaray Marina, Kratje Ricardo, Prieto Claudio

机构信息

Cell Culture Laboratory, Biochemistry and Biological Sciences School, Universidad Nacional del Litoral, Bv. Pellegrini 2750, Santa Fe, 3000, Argentina.

Biotechnological Development Laboratory, Biochemistry and Biological Sciences School, Universidad Nacional del Litoral, Santa Fe, Argentina.

出版信息

Methods Mol Biol. 2016;1403:155-66. doi: 10.1007/978-1-4939-3387-7_7.

DOI:10.1007/978-1-4939-3387-7_7
PMID:27076129
Abstract

Rabies is a viral infection of the central nervous system for which vaccination is the only treatment possible. Besides preexposure, vaccination is highly recommended for people living in endemic areas, veterinarians, and laboratory workers. Our group has developed rabies virus-like particles (RV-VLPs) with immunogenic features expressed in mammalian cells for vaccine applications. In this chapter the methods to obtain and characterize a stable HEK293 cell line expressing RV-VLPs are detailed. Further, analytical ultracentrifugation steps to purify the obtained VLPs are developed, as well as western blot, dynamic light scattering, and immunogold electron microscopy to analyze the size, distribution, shape, and antigenic conformation of the purified particles. Finally, immunization protocols are described to study the immunogenicity of RV-VLPs.

摘要

狂犬病是一种中枢神经系统的病毒感染,对此接种疫苗是唯一可行的治疗方法。除暴露前预防外,强烈建议生活在狂犬病流行地区的人群、兽医和实验室工作人员接种疫苗。我们的团队已开发出具有在哺乳动物细胞中表达的免疫原性特征的狂犬病病毒样颗粒(RV-VLPs)用于疫苗应用。在本章中,详细介绍了获得和鉴定表达RV-VLPs的稳定HEK293细胞系的方法。此外,还开发了用于纯化所得VLPs的分析超速离心步骤,以及用于分析纯化颗粒的大小、分布、形状和抗原构象的蛋白质印迹法、动态光散射法和免疫金电子显微镜法。最后,描述了免疫方案以研究RV-VLPs的免疫原性。

相似文献

1
Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies.用于疫苗应用的狂犬病病毒样颗粒的研发:生产、特性鉴定及保护研究。
Methods Mol Biol. 2016;1403:155-66. doi: 10.1007/978-1-4939-3387-7_7.
2
Rabies virus-like particles expressed in HEK293 cells.在人胚肾293细胞中表达的狂犬病病毒样颗粒。
Vaccine. 2014 May 19;32(24):2799-804. doi: 10.1016/j.vaccine.2014.02.031. Epub 2014 Mar 12.
3
Immunogenic virus-like particles continuously expressed in mammalian cells as a veterinary rabies vaccine candidate.作为一种兽用狂犬病疫苗候选物在哺乳动物细胞中持续表达的免疫原性病毒样颗粒。
Vaccine. 2015 Aug 20;33(35):4238-46. doi: 10.1016/j.vaccine.2015.03.088. Epub 2015 Apr 11.
4
A simplified roller bottle platform for the production of a new generation VLPs rabies vaccine for veterinary applications.一种用于生产新一代兽医用狂犬病 VLPs 疫苗的简化滚瓶平台。
Comp Immunol Microbiol Infect Dis. 2019 Aug;65:70-75. doi: 10.1016/j.cimid.2019.04.009. Epub 2019 Apr 30.
5
Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.从大肠杆菌表达的犬细小病毒衣壳蛋白的病毒样颗粒的自组装及其作为病毒样颗粒疫苗的应用。
Appl Microbiol Biotechnol. 2014 Apr;98(8):3529-38. doi: 10.1007/s00253-013-5485-6. Epub 2014 Jan 12.
6
Characterization of human enterovirus71 virus-like particles used for vaccine antigens.用于疫苗抗原的人肠道病毒71型病毒样颗粒的特性分析。
PLoS One. 2017 Jul 21;12(7):e0181182. doi: 10.1371/journal.pone.0181182. eCollection 2017.
7
Production of Rabies VLPs in Insect Cells by Two Monocistronic Baculoviruses Approach.昆虫细胞中两种单顺反子杆状病毒表达狂犬病 VLPs。
Mol Biotechnol. 2021 Nov;63(11):1068-1080. doi: 10.1007/s12033-021-00366-z. Epub 2021 Jul 6.
8
Virus-like particles expressing the nucleocapsid gene as an efficient vaccine against Rift Valley fever virus.表达核衣壳蛋白基因的病毒样颗粒作为裂谷热病毒的有效疫苗。
Vector Borne Zoonotic Dis. 2010 Oct;10(7):701-3. doi: 10.1089/vbz.2009.0248.
9
Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice.酵母中产生的类病毒颗粒可在小鼠中引发对柯萨奇病毒 A16 的保护性免疫。
Appl Microbiol Biotechnol. 2013 Dec;97(24):10445-52. doi: 10.1007/s00253-013-5257-3. Epub 2013 Oct 2.
10
Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C Mice.H7N9流感病毒样颗粒疫苗在BALB/C小鼠中诱导的体液免疫反应的特征
Viruses. 2015 Aug 4;7(8):4369-84. doi: 10.3390/v7082821.

引用本文的文献

1
Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes.用于疫苗目的的嵌合狂犬病-SARS-CoV-2 病毒样颗粒的设计和表征。
Appl Microbiol Biotechnol. 2023 Jun;107(11):3495-3508. doi: 10.1007/s00253-023-12545-w. Epub 2023 May 1.
2
Performance Comparison of Recombinant Baculovirus and Rabies Virus-like Particles production Using Two Culture Platforms.使用两种培养平台生产重组杆状病毒和狂犬病病毒样颗粒的性能比较
Vaccines (Basel). 2022 Dec 24;11(1):39. doi: 10.3390/vaccines11010039.
3
Production of Rabies VLPs in Insect Cells by Two Monocistronic Baculoviruses Approach.
昆虫细胞中两种单顺反子杆状病毒表达狂犬病 VLPs。
Mol Biotechnol. 2021 Nov;63(11):1068-1080. doi: 10.1007/s12033-021-00366-z. Epub 2021 Jul 6.
4
Vaccine Development Against COVID-19 Prior to Pandemic Outbreaks, Using Evolution and Reverse Genetics.在大流行爆发前利用进化和反向遗传学开发针对2019冠状病毒病的疫苗
Front Immunol. 2020 Aug 14;11:2051. doi: 10.3389/fimmu.2020.02051. eCollection 2020.